Thyroid Radiology Flashcards
Imaging modalities
Anatomic imaging: US is the best modality.
Functional Imaging
PET/CT scan
Anatomic imaging:
- Ultrasound, CT and MRI.
- Indicated to detect or characterize palpable or incidentally found thyroid nodule on other modalities.
- US is the best modality.
Functional Imaging
Iodine ( I123 or I131) scan. To evaluate for function of the thyroid gland or nodule in patient with abnormal thyroid function. Evaluate for distant metastatic disease.
PET/CT scan
scan- Staging and restaging of differentiated thyroid cancer
Radiograph
- Not useful to detect thyroid disease
- May incidentally suggest a thyroid lesion by noting mass effect on the soft tissues (often more obvious clinically) or on tracheal air column
The best modality to detect and characterize thyroid nodule.
US
Best modality to detect lymph node metastasis in postop patient of thyroid cancer.
US
incidentalomas
Nonpalpable nodules detected on US or other anatomic imaging studies
CT
Useful to define extension to lymph nodes and distant metastasis.
Good anatomic evaluation of the thyroid bed
Thyroid is:
-Hyperdense
-Hypervascular
MRI use
Useful in identifying infiltrative disease particularly in post-therapy neck where anatomy is distorted
Detection of deep nodal disease.
MSI results
Thyroid slightly hyperintense on T2.
Can’t differentiate solid vs. cystic nodule.
Can’t visualize microca.
Iodine Scan
- I 123 scan- To evaluate function of the thyroid gland and thyroid nodule in patient with abnormal thyroid function.
- I131 scan- Diagnostic and therapeutic role.
- Detect local and distant thyroid cancer metastasis.
- Treatment of hyperthyroidism as well as for well differentiated thyroid cancer.
T of F: No imaging modality can reliably differentiate between benign and malignant thyroid disease.
True. Tissue diagnosis by FNA should be obtained on suspicious lesions.
T or F: Nonpalpable nodules have the same risk of malignancy as palpable nodules with the same size.
True
Hot nodules prognosis
almost always benign, Cold nodule 15-25% cancer risk in the nodule